Altamira Therapeutics Ltd. Increase Decrease Through Conversion Of Convertible Instruments
Altamira Therapeutics Ltd. (CYTOF) reported Increase Decrease Through Conversion Of Convertible Instruments of CHF 8.02 million for the 12-month period ending 2023-12-31, per its 20-F/A filed 2024-04-22.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments · last filed 2025-04-30
CHF
| Period end | Increase Decrease Through Conversion Of Convertible Instruments 6 month | Increase Decrease Through Conversion Of Convertible Instruments 12 month |
|---|---|---|
| 2023-12-31 | 8.02M CHF 20-F/A · filed 2024-04-22 | |
| 2023-06-30 | 5.77M CHF 6-K · filed 2023-09-12 |
USD
| Period end | Increase Decrease Through Conversion Of Convertible Instruments 6 month | Increase Decrease Through Conversion Of Convertible Instruments 12 month |
|---|---|---|
| 2023-12-31 | $9.11M 20-F · filed 2025-04-30 | |
| 2023-06-30 | $6.42M 6-K · filed 2024-09-24 |